First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · IEX Real-Time Price · USD
25.81
-0.05 (-0.19%)
At close: Apr 17, 2024, 1:41 PM
25.82
+0.01 (0.04%)
After-hours: Apr 17, 2024, 4:15 PM EDT
FTXH Holdings List
As of Apr 15, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | MRK | Merck & Co., Inc. | 7.56% |
2 | PFE | Pfizer Inc. | 7.43% |
3 | BMY | Bristol-Myers Squibb Company | 7.28% |
4 | ABBV | AbbVie Inc. | 7.00% |
5 | JNJ | Johnson & Johnson | 6.97% |
6 | LLY | Eli Lilly and Company | 3.80% |
7 | AMGN | Amgen Inc. | 3.69% |
8 | CAH | Cardinal Health, Inc. | 3.64% |
9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.60% |
10 | UTHR | United Therapeutics Corporation | 3.60% |
11 | GILD | Gilead Sciences, Inc. | 3.58% |
12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.54% |
13 | VTRS | Viatris Inc. | 3.49% |
14 | BIIB | Biogen Inc. | 3.46% |
15 | JAZZ | Jazz Pharmaceuticals plc | 3.12% |
16 | ZTS | Zoetis Inc. | 2.88% |
17 | OGN | Organon & Co. | 2.67% |
18 | CRL | Charles River Laboratories International, Inc. | 2.11% |
19 | MEDP | Medpace Holdings, Inc. | 1.48% |
20 | PRGO | Perrigo Company plc | 1.47% |
21 | HALO | Halozyme Therapeutics, Inc. | 1.28% |
22 | INCY | Incyte Corporation | 0.98% |
23 | ALKS | Alkermes plc | 0.96% |
24 | EXEL | Exelixis, Inc. | 0.94% |
25 | NBIX | Neurocrine Biosciences, Inc. | 0.87% |
26 | PBH | Prestige Consumer Healthcare Inc. | 0.82% |
27 | ELAN | Elanco Animal Health Incorporated | 0.73% |
28 | ILMN | Illumina, Inc. | 0.62% |
29 | EXAS | Exact Sciences Corporation | 0.60% |
30 | KRYS | Krystal Biotech, Inc. | 0.57% |
31 | BMRN | BioMarin Pharmaceutical Inc. | 0.56% |
32 | ACLX | Arcellx, Inc. | 0.55% |
33 | ROIV | Roivant Sciences Ltd. | 0.50% |
34 | ITCI | Intra-Cellular Therapies, Inc. | 0.50% |
35 | IDYA | IDEAYA Biosciences, Inc. | 0.49% |
36 | SRPT | Sarepta Therapeutics, Inc. | 0.49% |
37 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.49% |
38 | IONS | Ionis Pharmaceuticals, Inc. | 0.49% |
39 | BPMC | Blueprint Medicines Corporation | 0.48% |
40 | MLTX | MoonLake Immunotherapeutics | 0.48% |
41 | VKTX | Viking Therapeutics, Inc. | 0.46% |
42 | MRUS | Merus N.V. | 0.45% |
43 | RARE | Ultragenyx Pharmaceutical Inc. | 0.44% |
44 | TGTX | TG Therapeutics, Inc. | 0.43% |
45 | KYMR | Kymera Therapeutics, Inc. | 0.43% |
46 | NUVL | Nuvalent, Inc. | 0.41% |
47 | ARVN | Arvinas, Inc. | 0.40% |
48 | ACAD | ACADIA Pharmaceuticals Inc. | 0.39% |
49 | CRSP | CRISPR Therapeutics AG | 0.37% |
50 | BEAM | Beam Therapeutics Inc. | 0.35% |
As of Apr 15, 2024